| Term 
 
        | CNS Drug   STIMULATION   Sensation acuity increased(greater awareness of environment)
   Motor activity increased(restlessness)
 |  | Definition 
 | 
        |  | 
        
        | Term 
 
        | CNS Drug   DEPRESSION   Sensation acuity decreased (lack of perception, drowsy, not alert)   Motor activity decreased (lethargic) |  | Definition 
 | 
        |  | 
        
        | Term 
 | Definition 
 
        | -state where one must increase dosage to keep the desired effect. (always occurs in process of physical addiction)
   "Metabolic" Tolerance -enzymes systems working differently, breaking drugs down faster, metabolizing/getting rid of drug faster.   "Receptor" Tolerance - up or down regulation of receptors, altering the need for drugs. |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |       -An adaptive physiological state that manifests by physical disturbances when withdrawn (withdrawal syndrome)   **Dependence causing drugs usually are both types at the same time.**
 |  | 
        |  | 
        
        | Term 
 | Definition 
 
        |     -a state of emotional reliance upon a drug in order to maintain a state of well-being. If tolerance does occur it is of "metabolic" type, no withdrawal symptoms.   **Degree of physical dependence is NOT synomymous with degree of "addiction"** |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Amphetamines (stimulates all areas of the brain)   d-amphetamine (dexedrine), methylpenidat (Ritalin), pemoline (Cylert)   Responses Observed |  | Definition 
 
        |   1.) Increased alertness, wakefulness, decreased fatigue.   2.) Mood elevation or euphoria, increased initiative   3.) Decreased appetite, but little effect in reducing food intake if eating for pyschological reasons. |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Amphetamines (stimulates all areas of the brain)   d-amphetamine (dexedrine), methylpenidat (Ritalin), pemoline (Cylert)   Mechanisms of Action
 |  | Definition 
 
        |   -incr. the release of NOREPI in the brain (CNS stimulation)   -incr. the release of DOPAMINE (causes side effects)   For AD-HD - incr. NOREPI which increases attention span of child. -Perhaps incr. dopamine helps |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Amphetamines (stimulates all areas of the brain)   d-amphetamine (dexedrine), methylpenidat (Ritalin), pemoline (Cylert)   Therapeutic Uses
 |  | Definition 
 
        | Schedule II 
 1.) Narcolepsy 
 2.) Weight control - highly abused, doesn't control psycholigical eating, tolerance occurs (too dangerous) 
 3.) AD-HD - Ritalin; classroom improvement in 70-80% -active -learning and discipline problems -short attention span |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Amphetamines (stimulates all areas of the brain)   d-amphetamine (dexedrine), methylpenidat (Ritalin), pemoline (Cylert)   Side/Toxic Effects
 |  | Definition 
 
        | 1.) CNS - nervousness, anxiety, sleeplessness. High dose: - schizophrenic behavior (incr. dopamine), hellucinations, paranoia, psychoses,tremors, dependence. 
 2.)Cardiovascular - incr. H.R., B.P., and possibly arrhythmias.   3.)Weightloss and malnutrition   4.)AD-HD - sleeplessness, excessive crying, suppresses growth (reversible if quit before bone closure) 
 5.)Poss. (rare) bone marrow supression. (periodic blood checks)
 |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Amphetamines (stimulates all areas of the brain)   d-amphetamine (dexedrine), methylpenidat (Ritalin), pemoline (Cylert)   Contraindications
 |  | Definition 
 
        | 1.) Insomnia or psychological disorders (suicidal, schizophrenia, etc.) 
 2.) MAO inhibitors 
 3.) Hypertension, cardiac arryhthmias 
 4.) Anorexia 
 Drug interactions: anticholinergics, anticoagulants, anticonvulsants, tricyclic (req. dose adjustments). |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Xanthines (caffeine, theobronmine, theophylline) min. therapeutic use   Responses observed
 
 |  | Definition 
 
        | 1.) CNS stimulation - incr. alertness, decr. fatigue caffeine > theophylline > theobromine 
 2.) Cardiac stimulant (rate and force of contraction) T>T>C
 
 3.) Constricts blood vessels in brain, coffee may help headache (if causes is dilated blood vessels) 
 4.) Diuresis (theophylline > theobromine > caffeine)
 
 5.)Bronchiorelaxation (req. higher dose than CNS effects) T>T>C |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Xanthines (caffeine, theobronmine, theophylline) min. therapeutic use   Mechanism of Action
 
 |  | Definition 
 
        | -inhibits breakdown of cyclic AMP.   -incr. CNS activity   -dilates bronchiles, pulmonary blood vessels, but constricts cerebral vessels.   -**Activates P450 enzymes so affecsts metabolism of many drugs. |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Xanthines (caffeine, theobronmine, theophylline) min. therapeutic use   Therapeutic Uses
 
 |  | Definition 
 
        |   1.) Counter drowsiness   2.) Asthma, bronchitis, empysema (aminophylline - H2O soluble version of theophylline)   3.) Pain from headache (caffeine in OTC), no activity alone, only with other analgesics (painkiller)   |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Xanthines (caffeine, theobronmine, theophylline) min. therapeutic use   Side Effects
 
 |  | Definition 
 
        | 1.) Incr. heart erate, cardiac arrhythmias   2.) Incr. gastric secretion (caffeine worst culprit)   3.) Diuresis   4.) Excess CNS stimulation - convulsions, insomnia   5.) Withdrawal may causes headache and irritability |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Xanthines (caffeine, theobronmine, theophylline) min. therapeutic use   Cautions
 
 |  | Definition 
 
        |     1.) Cardiac arrhythmias   2.) Ulcers   3.) Possibly birth defects with large doses in small animals, no sign in humans. |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Cocaine (cola leaves - powerful CNS stimulant - schedule II)     Same responses, MOA, side effects, cautions as Amphetamines 
 |  | Definition 
 
        |       Uses - local anesthetics, only allowed in hospital/clinical setting.   -seems to elevate threshold for excitement of neuron by decreasing permeability to all ions.     |  | 
        |  | 
        
        | Term 
 
        | CNS Stimulants       Cocaine (cola leaves - powerful CNS stimulant - schedule II)     Side Effects
 
 |  | Definition 
 
        |   Early: CNS stim. (anxiety, restlessness, confusion, dizziness, tremors, convulsions; incr. H.R. and B.P.   Later: may get depression, unconsciousness, and death. Cardio - will see later depressant action directly on heart (bradycardia, hyopotension, cardiac arrest)         |  | 
        |  | 
        
        | Term 
 
        | CNS Depressant Terms: 
 CNS depressant 
 Sedative 
 Hypnotics 
 General anesthetic |  | Definition 
 
        | CNS depressant - agent decr. excitability of tissue in CNS. All drugs can be sedative, hypnotic, or gen. anesthetic depending on dose.
 
 Sedative - administered for mild drowsiness or to reduce restlessness or anxiety 
 Hypnotic - admin. to induce sleep or allow to stay asleep, (can be aroused from sleep). *3-4 times dose of sedative. 
 Gen. anesthetic - depress CNS to cause unconsciouness (unarousable sleep), as well as analgesia. |  | 
        |  | 
        
        | Term 
 
        | CNS Depressant         Barbiturates |  | Definition 
 
        | -15 kinds commonly avail. in U.S (50 FDA approved) 
 Differ in: -speed with which effects occur -duration of action (into blood same rate, brain diff.) -all can be taken orally, or I.V   phenobarbital (Lumina) - slow onset, long acting(all day) seco & pentobarbital (Nembutal) - interm. acting (2-4hrs) thiopental (Pentothal) - onset in secs., duration in mins.
 |  | 
        |  | 
        
        | Term 
 
        | CNS Depressant         Non-Barbiturates (aka minor tranquillizers)   *Does not have barbiturate structure*
 |  | Definition 
 
        |       -Ethyl alcohol   -Benzodiazepines: flurazepam (Dalmane)                           diazepam (Valium)                           chlorodiazepoxide (Librium) |  | 
        |  | 
        
        | Term 
 
        | CNS Depressant       Non-/Barbiturates (classified as sedative-hypnotics)     Useful Therapeutic Reponses
 |  | Definition 
 
        |     -Reduced anxiety   -Sedation (drowsiness)   -Hypnosis (sleep)   -General anesthesia |  | 
        |  | 
        
        | Term 
 
        | CNS Depressant       Non-/Barbiturates (classified as sedative-hypnotics)     Mechanism of Action - Barbituates
 |  | Definition 
 
        | -depress all areas of brain   -inhibit reticular activating system.   -Prob. enhance GABA receptor complex, and enhance Cl- entrance to neurons and hyperpolarize cells. 
 -GABA independent |  | 
        |  | 
        
        | Term 
 
        | CNS Depressant       Non-/Barbiturates (classified as sedative-hypnotics)     Mechanism of Action - Benzodiazepines |  | Definition 
 
        | -Bind to special receptor that decr. acitvity of brain. Also incr. activity of GABA.   -When GABA concentration decr. so does degree of depression.   -GABA dependent |  | 
        |  | 
        
        | Term 
 
        | CNS Depressant       Non-/Barbiturates (classified as sedative-hypnotics)     Mechanism of Action - Alcohol |  | Definition 
 
        | -seems to incr. GABA activity with short term use.   -long term use (alcoholics) decre. GABA, therefore decr. anti-anxiety effects, thats why need to drink more and more to relieve anxiety.   -large ingestion of alcohol incr. dopamine release   **All activate P450 enzyme = incr. metab. of drugs |  | 
        |  |